Medtronic (MDT) Curent Deferred Tax Liability (2014 - 2015)

Medtronic (MDT) reported Curent Deferred Tax Liability of $142.0 million for Q4 2015, up 18.33% sequentially from $120.0 million in Q3 2015.

Medtronic (MDT) Curent Deferred Tax Liability (2014 - 2015) Analysis & Trends

Medtronic (MDT) has 2 years of Curent Deferred Tax Liability data on file, last reported at $142.0 million in Q4 2015.

For the quarter ending Q4 2015, Curent Deferred Tax Liability changed N/A year-over-year to $142.0 million; the trailing twelve-month figure through Oct 2015 stood at $142.0 million (changed N/A YoY), and the FY2015 full-year result was $119.0 million, up 526.32% from the prior year.
Curent Deferred Tax Liability advanced to $142.0 million in Q4 2015, from $120.0 million in the prior quarter.
In the past five years, Curent Deferred Tax Liability ranged from a high of $142.0 million in Q4 2015 to a low of $19.0 million in Q2 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Curent Deferred Tax (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	-
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	-
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	-
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Steris	20.59 Bn	20.16 Bn	697.10 Mn	-

Download Data